
    
      The treatment period consists of 6 cycles. Cycles 1 and 2 involve the regional administration
      of oxaliplatin via PEDD-PRVI with systemic FOLFIRI. During cycles 1 and 2, patients are
      evaluated on days 1, 2, 4, and 8. Cycles 3 through 6 include the systemic administration of
      standard of care FOLFIRINOX. During cycles 3 through 6, patients are evaluated on days 1 and
      8.
    
  